FDA Approved: BEXAROTENE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma, Inc.'s original application for generic Bexarotene. The drug is indicated for the treatment of cutaneous T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

ORIG AP for BEXAROTENE (BEXAROTENE)